SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Strategy: Offers Up To $4.13 Bln Of 10.00% Series A Perpetual Stride Preferred Stock - SEC Filing

SquawkNews Desk 2 updates Updated Nov 02, 2026, 02:35 PM UTC

Story updates

02:26:54 PM UTC
SquawkNews
Strategy: Offers Up To $2.10 Bln Of 8.00% Series A Perpetual Strike Preferred Stock - SEC Filing
02:35:35 PM UTC
SquawkNews
Strategy: Offers Up To $1.66B Of 10.00% Series A Perpetual Strife Preferred Stock - SEC Filing

Related stories

Tax Department Searches Muthoot Finance Office on Oct. 29-30 Muthoot Finance says the tax department conducted a search and seizure at its registered office on Oct. 29-30, 2026. M impact | REGULATION | Nov 02, 2026, 03:30 PM UTC Indofood Agri Unit Cooperates With Singapore Authorities in Haze Probe Indofood says its agriculture unit is cooperating with Singapore authorities in a haze probe. L impact | REGULATION | Nov 02, 2026, 03:25 PM UTC China Central Bank Intervenes Again to Stem Stock Market Declines China's central bank intervened again on Monday to stem declines in the country's stock market. The iShares MSCI China A ETF, which tracks domestically listed companies, is down 14 M impact | REGULATION | Nov 02, 2026, 03:07 PM UTC Lupin Wins FDA Approval for Amifampridine Tablets The FDA approved Lupin’s 10 mg amifampridine tablets, bioequivalent to Firdapse. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivit M impact | REGULATION | Nov 02, 2026, 02:47 PM UTC Belgian Government in Crisis After Budget Talks Collapse Belgium’s prime minister offers resignation after budget talks collapse. M impact | REGULATION | Nov 02, 2026, 02:45 PM UTC Inovio shares surge 186% after FDA approves rare-disease treatment Inovio Pharmaceuticals shares surged 186% after the FDA approved a treatment for a rare respiratory condition. H impact | REGULATION | Nov 02, 2026, 02:45 PM UTC